TrialHuman vaccines & immunotherapeutics2026

Safety and immunogenicity of an mRNA COVID-19 vaccine administered to adults: A phase 2, randomized, active-controlled trial.

Robynne Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.